Roles of VEGF type 1 receptor signaling in pathologicalangiogenesis/lymphangiogenesis

VEGF 1 型受体信号传导在病理性血管生成/淋巴管生成中的作用

基本信息

  • 批准号:
    21390072
  • 负责人:
  • 金额:
    $ 11.9万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2009
  • 资助国家:
    日本
  • 起止时间:
    2009 至 2012
  • 项目状态:
    已结题

项目摘要

Vascular endothelial growth factor (VEGF) is known as a major propangiogenic factor. VEGF has 3 receptors, namely VEGFR1 (Flt-1), VEGFR2 (Flk-1/KDR) and VEGFR3 (Flt-4). We had previously reported that the magnitude of cytokine-mediated release of SDF-1 from platelets and the recruitment of nonendothelial CXCR4+ VEGFR1+ hematopoietic progenitors, ‘hemangiocytes,’ constitute the major determinant of angiogenesis. We tested that Flt-1 Tyrosine Kinase (TK) signaling enhances angiogenesisby stimulating Stem Cell Factor (SCF) and MMP-9 by bone marrow stem cells. Blood flow recovery in TKKO was significantly delayed compared to WT. Compared to WT, plasma concentrations of SCF and pro-MMP9 were significantly reduced in TKKO. There was no significant difference between the concentrations of VEGF in both mice, but in TKKO, platelets-deposited microvascular density was significantly suppressed. These results suggested that the signaling of the Flt-1 is essential for recovering from acute ischemic conditions. Administration of selective VEGFR1 agonist may be useful to treat the ischemia, and may become a novel therapeutic strategy in regenerative cardiovascular medicine.
血管内皮生长因子(VEGF)被称为主要的血管生成因子,VEGF有3种受体,即VEGFR1(Flt-1)、VEGFR2(Flk-1/KDR)和VEGFR3(Flt-4)。细胞因子介导的血小板 SDF-1 释放量和非内皮 CXCR4+ VEGFR1+ 造血细胞的募集我们测试了 Flt-1 酪氨酸激酶 (TK) 信号通过刺激骨髓干细胞的干细胞因子 (SCF) 和 MMP-9 来增强血管生成。与 WT 相比,TKKO 中 SCF 和 pro-MMP9 的血浆浓度显着降低,两者中 VEGF 的浓度没有显着差异。但在 TKKO 中,血小板沉积的微血管密度被显着抑制。这些结果表明,Flt-1 信号传导对于急性缺血性疾病的恢复至关重要,并且可能有助于治疗缺血。成为再生心血管医学的一种新型治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thromboxane A_2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells
血栓素 A_2 受体信号传导通过 P-选择素介导的肿瘤细胞与血小板和内皮细胞的相互作用促进肿瘤定植
  • DOI:
    10.1111/j.1349-7006.2012.02200.x
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Matsui Y; Amano H; Ito Y; Eshima K; Suzuki T; Ogawa F; Iyoda A; Satoh Y; Kato S; Nakamura M; Kitasato H; Narumiya S; Majima M
  • 通讯作者:
    Majima M
Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema
COX-2 在继发性淋巴水肿淋巴管生成和淋巴液流恢复中的作用
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Kashiwagi S; Hosono K; Suzuki T; Takeda A; Uchinuma E; Majima M
  • 通讯作者:
    Majima M
The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model
诱导型前列腺素 E 合酶 mPGES-1 调节小鼠着床模型中子宫内膜组织的生长和血管生成
  • DOI:
    10.1016/j.biopha.2010.12.008
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Numao A; Hosono K; Suzuki T; Hayashi I; Uematsu S; Akira S; Ogino Y; Kawauchi H; Unno N; Majima M
  • 通讯作者:
    Majima M
Roles of prostaglandin E2-EP1 receptor signaling in regulation of gastric motor activity and emptying
前列腺素 E2-EP1 受体信号在胃运动活动和排空调节中的作用
  • DOI:
    10.1152/ajpgi.00524.2009
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizuguchi S; Ohno T; Hattori Y; Ae T; Minamino T; Satoh T; Arai K; Saeki T; Hayashi I; Sugimoto Y; Narumiya S; Saigenji K; Majima M
  • 通讯作者:
    Majima M
Estimating the contribution of genes to variation in renal drug clearance by active secretion using multiple data from clinical phase I studies.
使用临床 I 期研究的多个数据估计基因对主动分泌引起的肾脏药物清除率变化的贡献。
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujita T; Kumagai Y; Nakahara I; Ohtani Y; Majima M.
  • 通讯作者:
    Majima M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAJIMA Masataka其他文献

MAJIMA Masataka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAJIMA Masataka', 18)}}的其他基金

Roles of humoral and neural factors in angiogenesis and lymphangiogenesis in pathological conditions and their significance in molecular targeting therapy
病理条件下体液和神经因子在血管生成和淋巴管生成中的作用及其在分子靶向治疗中的意义
  • 批准号:
    15390084
  • 财政年份:
    2003
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Preventive roles of renal Kallikrein-kinin system for hypertension
肾激肽释放酶-激肽系统对高血压的预防作用
  • 批准号:
    07672472
  • 财政年份:
    1995
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Role of Tspan18 in the intracellular trafficking of VEGF receptor
Tspan18 在 VEGF 受体细胞内运输中的作用
  • 批准号:
    19K07389
  • 财政年份:
    2019
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Physiological and pathological analysis of intestinal mucosa lymphatic endothelial cells.
肠粘膜淋巴内皮细胞的生理病理分析。
  • 批准号:
    19K22665
  • 财政年份:
    2019
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Establishment of new strategy targeting lymphangiogenesis in the patients with renal diseases
肾病患者淋巴管生成新策略的建立
  • 批准号:
    15K09287
  • 财政年份:
    2015
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel biomarker for tumor anti-angiogenic therapy based on molecular biology
基于分子生物学的肿瘤抗血管生成治疗的新型生物标志物
  • 批准号:
    26461938
  • 财政年份:
    2014
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New therapeutic strategies targeting lymphatic vessels for retinochoroidal disease
针对视网膜脉络膜疾病的淋巴管新治疗策略
  • 批准号:
    25713057
  • 财政年份:
    2013
  • 资助金额:
    $ 11.9万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了